BiotechTube
Alissa Healthcare

Alissa Healthcare

London, United Kingdom· Est.
alissahealthcare.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $2M

Overview

Alissa Healthcare Research Limited is a UK-based, privately held generic and specialty pharmaceutical company. Since its founding in 2006, it has established itself as an MHRA-approved entity, focusing on providing value-driven medicines to the National Health Service (NHS) and retail pharmacies. Its core business involves the end-to-end process from development and licensing to marketing and distribution, positioning it as a service-oriented partner in the generic drugs sector. The company appears to be a commercial-stage, revenue-generating business with a lean operational model typical of many specialty generic firms.

Generic Drugs

Technology Platform

Regulatory and development expertise in formulating, licensing, and commercializing bioequivalent generic and specialty pharmaceutical products.

Funding History

1
Total raised:$2M
Seed$2M

Opportunities

Growing NHS focus on cost-saving generics and the higher-margin specialty generics segment provide significant market opportunities.
Potential expansion into the EU market, though complex post-Brexit, offers a long-term growth path.

Risk Factors

Faces intense price competition and severe margin pressure in the generic drug market.
Regulatory complexities from Brexit and reliance on global supply chains for APIs create operational and compliance vulnerabilities.

Competitive Landscape

Operates in the highly competitive UK generic pharmaceutical sector, competing against large multinational generics firms (e.g., Teva, Sandoz) and other UK-focused specialty generics companies. Differentiation is achieved through service, niche portfolio selection, and regulatory execution.

More companies in Small Molecule Drugs →More companies in United Kingdom →